Actividad comparativa de daptomicina frente a microorganismos grampositivos: programa SENTRY España (2002-2006)

The sustained antimicrobial activity of daptomycin against staphylococci, enterococci, and streptococci in Spain makes this antibiotic an excellent therapeutic option in severe infection caused by gram-positive microorganisms, including those with multiresistance.